USD 786.51 million
Report ID:
SQMIG35B2208 |
Region:
Global |
Published Date: May, 2024
Pages:
219
|Tables:
61
|Figures:
75
Malaria Diagnostics Market size was valued at USD 844.51 Million in 2023 and is poised to grow from USD 884.46 Million in 2024 to USD 1340.65 Million by 2032, growing at a CAGR of 4.73% during the forecast period (2025-2032).
Malaria is a parasitic disease which is transmitted through the bite of an infected anopheles mosquitoes. These mosquitoes carry the Plasmodium parasite, which is then transmitted to humans during a bite. Upon entering the human body, these parasites initially grow in the liver before entering the bloodstream and infect the red blood cells. Common symptoms of malaria in humans include fever, vomiting, weakness, and headache. Over recent years, there has been a significant expansion in the global market for malaria diagnostics.
In recent years, the global malaria diagnostics market has witnessed notable growth, driven by key trends and innovations in diagnostic technologies. Technological advancements, particularly in molecular diagnostics and RDTs, have changed the malaria diagnosis by offering greater sensitivity, specificity and ease of use. Moreover, the increasing adoption of point-of-care testing solutions has facilitated timely diagnosis, especially in resource-limited settings where access to laboratory facilities is limited. The rising awareness about the importance of early detection of malaria along with the government initiatives and fundings from organizations like the global fund, has pushed the market growth while encouraging the development and deployment of innovative diagnostic tools.
However, the market faces several restraints that could impede its growth trajectory. Limited healthcare infrastructure and access to diagnostic services in remote and underserved regions pose significant challenges for malaria diagnosis. Affordability and accessibility of diagnostic tests remain key concerns, particularly in low-income countries where the burden of malaria is highest. Moreover, accuracy and reliability issues with some diagnostic tests, as well as regulatory hurdles, may hinder market expansion efforts. Addressing these challenges will require collaborative efforts from stakeholders across the public and private sectors to develop cost-effective, reliable, and culturally sensitive diagnostic solutions that can effectively combat malaria on a global scale.
Global Market Size
USD 786.51 million
Largest Segment
Rapid Diagnostic Tests
Fastest Growth
Molecular Diagnostic Tests
Growth Rate
4.73% CAGR
To get more reports on the above market click here to Buy The Report
The global malaria diagnostics market is by diagnostic tests, end-user and region. Based on diagnostics test, the market is segmented into rapid diagnostic tests, molecular diagnostic tests and microscopic diagnostic tests. Based on end-user, the market is segmented into hospitals, diagnostic centres and clinics. And lastly, based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Diagnostic Tests
Based on diagnostics test, the market is segmented into rapid diagnostic tests, molecular diagnostic tests and microscopic diagnostic tests.
The rapid diagnostic tests are the largest segment in the global malaria diagnostics market. The Rapid Diagnostic Tests (RDTs) segment was accounted for a revenue share of 53.69% in 2022. RDTs have gained importance due to their ease of use, rapid results and suitable for use in limited resource environment where malaria is most prevalent. Unlike microscopy, which requires skilled personnel and laboratory infrastructure, RDTs can be performed by minimally trained personnel, making them accessible even in remote areas. RDTs offer quick results, typically within 15-20 minutes and helps in quick diagnosis and timely treatment initiation, which is crucial for effective management of malaria. This further drives the demand in places where patients are in huge amounts. Hence, the convenience, accessibility, and efficiency of RDTs position them as the largest segment in the malaria diagnostics market.
The fastest-growing segment in the global malaria diagnostics market is Molecular Diagnostic Tests segment. Molecular diagnostic tests, such as polymerase chain reaction (PCR) assays, are gaining momentum due to their high sensitivity and specificity in detecting malaria parasites, even at low levels of infection. These tests offer several advantages over traditional methods like microscopy and RDTs such as their ability to detect different species of malaria parasites and differentiate between active infection and past exposure. Furthermore, new advancements in molecular technologies have led to the development of more portable, affordable, and user-friendly molecular diagnostic platforms, expanding their utility in diverse settings. With increasing emphasis on accurate diagnosis for malaria elimination and eradication efforts, the demand for molecular diagnostic tests is expected to rise steadily, making it the fastest-growing segment in the malaria diagnostics market.
Analysis by End-User
Based on end-user, the market is segmented into hospitals, diagnostics centres and clinics.
The largest segment in the malaria diagnostics market is the hospitals segment. Hospitals serve as the central hub for healthcare delivery, offering a wide range of medical services including diagnosis and treatment of malaria cases. They often have comprehensive laboratory facilities equipped with various diagnostic tools and technologies, allowing for prompt and accurate malaria testing. Hospitals cater to a diverse patient population, including individuals seeking treatment for severe malaria cases, making malaria diagnosis a routine part of their services. Moreover, hospitals typically have access to skilled healthcare professionals, including laboratory technicians and infectious disease specialists, ensuring high-quality malaria diagnosis and management.
The diagnostic centres segments are the fastest-growing segment in the malaria diagnostics market. Diagnostic centres are specialized facilities solely focused on diagnostic procedures which also includes malaria testing. They offer several advantages contributing to their rapid growth. Firstly, diagnostic centres often use advanced technologies and equipment, allowing for highly accurate and efficient malaria diagnosis. Secondly, these centres are increasingly being established in urban and rural areas, improving access to diagnostic services, especially in underserved regions where malaria is endemic. lastly, they also often provide specialized services and expertise, attracting patients seeking precise and timely diagnosis for malaria and other infectious diseases. Furthermore, with the growing emphasis on early detection and management of malaria for effective disease control and eradication, the demand for specialized diagnostic centres offering dedicated malaria testing services is expected to rise, making it the fastest-growing segment in the malaria diagnostics market.
To get detailed analysis on other segments, Request For Free Sample Report
Based on the geography, the global malaria diagnostics market is segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Middle East & Africa is considered as the leading region in the global malaria diagnostics market. The African region had the highest revenue share of 88.17% in 2022. P. falciparum is the most prevalent malarial parasite in this region and was accounted for an estimated 99% of all cases in Africa. According to the WHO, an estimated 92.0% of global malaria cases and 93% of global malarial deaths were recorded in this region. These facts are indicative of the rising prevalence of malaria in Africa. This region bears the highest burden of malaria globally, with a substantial portion of malaria cases and deaths occurring here. Factors contributing to the dominance of this segment include the endemic nature of malaria in many countries across Africa, where the disease is a major public health concern. Additionally, limited access to healthcare resources, including diagnostic facilities and trained personnel, often demands for the use of RDTs and other point-of-care diagnostics in resource-constrained settings. Moreover, international organizations, governments and non-profit organizations have been actively involved in scaling up malaria control and elimination efforts in the region, thereby driving the demand for malaria diagnostics.
The fastest-growing region in the global malaria diagnostics market is likely the Asia Pacific. While Africa bears the highest burden of malaria globally, Asia Pacific is experiencing significant strides in malaria control and elimination efforts. In Southeast Asia, the market is estimated to hold the second position with India accounting for the largest share of the regional market. The Southeast Asian region is expected to grow at a CAGR of 5.0%. Countries such as India, Indonesia, and Myanmar, have made considerable progress in reducing malaria transmission through extensive vector control measures, improved access to healthcare services, and effective treatment strategies. As a result, there is a growing emphasis on accurate and timely diagnosis of malaria to support these elimination efforts. With the rising awareness about the disease and increasing funding from the private sector, the need for diagnostic testing and care-based surveillance systems is anticipated to increase. Huge investments in healthcare infrastructures and collaborations between governments, international organizations, and private sectors are driving the expansion of malaria diagnostic services in the Asia Pacific region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Higher Malaria Burden in Endemic Regions
Rising Travel and Migration
Restraints
Limited Research and Development
Resistance to Antimalarial Drugs
Request Free Customization of this report to help us to meet your business objectives.
The global malaria diagnostics market is moderately competitive and consists of several major players. It is characterised by the presence of established multinational corporations, mid-sized companies, and emerging players. Key players such as Abbott Laboratories, BioMérieux SA, and F. Hoffmann-La Roche Ltd dominate the market with their extensive product portfolios, global presence, and strong distribution networks. These companies invest significantly in R&D activities to innovate and introduce advanced diagnostic technologies for malaria detection. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are common strategies employed by market players to expand their market share and enhance their competitive position. However, the market also witnesses the entry of smaller players and startups focusing on niche segments or innovative diagnostic approaches, contributing to market dynamism and fostering competition. The competitive landscape of the malaria diagnostics market is driven by technological advancements, regulatory approvals, market expansion efforts, and the pursuit of novel diagnostic solutions to address the global burden of malaria effectively.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global malaria diagnostics market analysis, the malaria diagnostics market is expected a promising growth potential, driven by advancements in diagnostic technologies, increasing awareness about the importance of early detection, and strategic initiatives from global health organizations. based on diagnostic tests, rapid diagnostic tests are dominating due to their accessibility and ease of use, while molecular diagnostic tests offer enhanced accuracy and sensitivity. And based on end-users, hospitals are considered as the biggest users in the market. Regional insights highlight significant opportunities for market expansion in emerging economies, particularly in Asia Pacific and Africa, where the burden of malaria is high. However, challenges such as limited healthcare infrastructure, affordability issues, and regulatory constraints remain key restraints that need to be addressed. Despite these challenges, concerted efforts from stakeholders across sectors can pave the way for the development of innovative, accessible, and reliable diagnostic solutions, ultimately contributing to the global fight against malaria.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 844.51 Million |
Market size value in 2032 | USD 1340.65 Million |
Growth Rate | 4.73% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Malaria Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Malaria Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Malaria Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Malaria Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35B2208
sales@skyquestt.com
USA +1 351-333-4748